knowledge -WSS

knowledge

author：knowledge 2025-08-11 07:58:33 - browse：2976

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readout LOUD podcast: Venture capital turmoil, obesity drug competition

WSS

Pharma’s losing bet in New Jersey

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

New research sheds light on how often breast cancer is overdiagnosed

RSV shot was 90% effective at preventing hospitalizations in kids

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

leisure time

knowledge

focus

Novavax promises a turnaround & Lilly roils the obesity market

U.S. death rates show how politics are affecting public health

Hepatitis C has a cure — but many Americans still lack access to it

With psoriasis trial ahead, Alumis raises $259 million

Tori Bowie and the unacceptable rates of Black maternal death

NEJM study link tiny plastics in blood vessels to heart problems

Psychedelics group wrestles with new pharma identity

Should insurance cover cosmetic surgery?

Activists slam private health insurers over coverage restrictions

Sen. Paul opposes bill to ban Chinese biotechs

hotspot

Change Healthcare payments predicted restored March 15

UnitedHealth quietly bought dozens of outpatient centers

Change Healthcare payments predicted restored March 15

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Beyond aggravation: Constipation is an American epidemic

First medicine developed to treat MASH expected to be approved soon

leisure time

hotspot

focus

hotspot